News center | India​

Feb 21, 2018

Philips launches Healthcare@home services in Chennai with the ICU@home

Chennai/New Delhi: Philips India Ltd, a leading health technology company, announces the expansion of its Healthcare@home services to Chennai, with the launch of ICU@home. The new service will provide intensive care unit equipment and high-quality medical care at home for patients, and has been developed in consultation with doctors and hospitals. The service offers ICU-trained nurses providing care and doctors remotely monitoring the patient.

Philips has expanded its homecare services beyond Respiratory and Critical care, providing high-quality and extensive range of health care facilities at home, across India. The new care areas include specialised doctor visits, physiotherapy and rehab services, doctor’s consultation and patient management, drug infusion therapies, minimizing the need for hospitalization for various diseases and 24hrs nursing support. Most of these services are backed by its connected care platform, making remote monitoring possible and driving availability of hospital like care at home. The new customised services supported by cutting-edge healthcare technology, patient monitoring systems helps to assist an even wider set of patients, in both short term (non-chronic) and long term (chronic) care segments.

In India, Philips entered home health with respiratory care and soon forayed into the full spectrum of high quality medical care for chronic and other long term illnesses. Over the last several months, Philips Homecare Services has helped patients and families ease transition from hospital to home, recover faster and better in comfort of their homes, while under continued care of doctors. Hospitals too have benefited from this initiative, as they can now focus on more critical care areas requiring investigations and interventions. We are excited to bring our expanded offering to Chennai and look forward to working closely with hospitals, doctors and patients.

Richa Singh

Business Leader Philips Healthcare@home, Philips Indian sub-continent

The ICU services provided by Healthcare@Home are cost effective compared to extended hospital stay. The company takes an integrated approach to provide the expertise of a hospital in the comfort of a home through expert physicians, well-trained caregivers, and cutting-edge medical care devices. Over the last few months it has successfully introduced this service across 4 cities including Delhi, Mumbai, Bangalore and Hyderabad; bringing expert care  and technology to patients in a hospital like set up at home, making things easier for both the patient and care givers.

Notes to the journalist  

1.       As of now, Philips has provided home care services to more than 2500 patients

2.       More than 200 doctors working currently with Philips as a part of care

3.       Philips works directly with doctors in more than 200 hospitals across cities

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at

Click here to read moreClick here to read less



Arshiya Ahmed 

Tel: +91 8377984933 

Geetika Bangia

Geetika Bangia

Sr. Manager Corporate Communications

Tel: +91 98181 02133

Share on social media

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.